Importing Ancillaries and IMPs for clinical trials in the Asia-Pacific region presents numerous challenges. Navigating diverse regulatory landscapes, and logistical complexities, ensuring quality control, and managing timeliness and costs are critical hurdles. Effective risk mitigation strategies are essential for overcoming potential disruptions. Overall, addressing these challenges is vital for the successful execution of clinical trials […]